NFG
ENZN

Next Financial Group’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Next Financial Group’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-60
Closed – – 2521
2016
Q2 		$0 Hold
60
– – ﹤0.01% 1940
2016
Q1 		$0 Hold
60
– – ﹤0.01% 1966
2015
Q4 		$0 Hold
60
– – ﹤0.01% 2045
2015
Q3 		$0 Hold
60
– – ﹤0.01% 2059
2015
Q2 		$0 Sell
60
-500
-89% -$637 ﹤0.01% 2053
2015
Q1 		$0 Hold
560
– – ﹤0.01% 2041
2014
Q4 		$1K Hold
560
– – ﹤0.01% 1867
2014
Q3 		$1K Hold
560
– – ﹤0.01% 2478
2014
Q2 		$1K Buy
+560
New +$534 ﹤0.01% 1193

Other funds holding ENZN

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Next Financial Group's ENZN Position: Q3 2016 in Review

Next Financial Group sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2016, closing a stake of 60 shares.

Next Financial Group first reported a position in ENZN in Q2 2014 and held it in 9 quarters. The position peaked at $1K in Q4 2014. 4 funds tracked by Wall St. Rank hold ENZN as of Q3 2016.

  • Next Financial Group reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2016 after selling out during the quarter.
  • Next Financial Group sold 60 ENZON PHARMACEUTICALS INC shares in Q3 2016.
  • Next Financial Group first reported a position in ENZON PHARMACEUTICALS INC in Q2 2014 and held it in 9 quarters.
  • Next Financial Group's ENZON PHARMACEUTICALS INC position peaked at $1K in Q4 2014.
  • 4 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2016.

Based on Next Financial Group's 13F filing for Q3 2016, filed 1 Nov 2016.